Pharmaceutics & Novel Drug Delivery Systems

Drug-Device Combinations: Integration and Optimization for Enhanced Delivery

Drug-device combinations have emerged as powerful therapeutic interventions, combining the benefits of both pharmaceutical agents and medical devices. This session will focus on the integration and optimization of drug-device combinations to enhance drug delivery and therapeutic outcomes. Drug-device combinations involve the strategic pairing of drugs with specialized delivery systems, such as implants, patches, inhalers, or infusion pumps. The session will explore the design, development, and optimization of these combinations, emphasizing the seamless integration of drug and device components. Attendees will gain insights into the challenges and considerations in developing effective drug-device combinations, including compatibility, stability, and biocompatibility. Discussions will cover topics such as device engineering, drug formulation, and patient-centered design. The session will also highlight the clinical applications of drug-device combinations across various therapeutic areas, such as cardiovascular diseases, neurology, and diabetes management. The integration of drugs with devices offers the potential for targeted drug delivery, personalized medicine, and improved patient outcomes. Furthermore, discussions will address regulatory considerations, manufacturing challenges, and the future directions of drug-device combinations. By focusing on the integration and optimization of drug-device combinations, this session aims to foster collaboration, promote innovation, and advance the development of effective and patient-friendly therapeutic solutions.

Overall, this session on drug-device combinations will showcase the latest advancements and explore the potential of these integrated systems in enhancing drug delivery and therapeutic efficacy. It will serve as a platform for researchers, clinicians, and industry professionals to exchange knowledge, foster collaborations, and shape the future of drug-device combinations.